MarketInOut Stock Screener Log In | Sign Up

Illumina Inc

NASDAQ • Healthcare • Diagnostics & Research • Quote as of 10/30/2026
Illumina Inc stock price and volume chart

Company Profile

IndustryDiagnostics & Research
SectorHealthcare
ExchangeNASDAQ
Market Capitalization35,634 mln
Float150 mln
Earnings Date02/11/2027

EPS

5.36
Stretched

P / E

44.03
High premium

Piotroski F-Score

8 / 9
Very strong

Beneish M-Score

-2.68
Likely reliable

1-Year Forecast

249.50
Modest upside

Relative Strength

15 / 100
Significantly lagging

Business Description

Illumina is a San Diego-based company founded in 1998 that makes tools and equipment for reading and analyzing DNA. Its products are used by research institutions, hospitals, pharmaceutical companies, and diagnostic labs across the Americas, Europe, Asia, the Middle East, and Africa. The company also offers services such as prenatal testing and cancer-related genomic analysis, and works with partners like Labcorp and the Center for Data-Driven Discovery in Biomedicine to advance research in oncology, pediatric cancer, and rare diseases.

Key Fundamentals

EPS5.36
P/E44.03
ROE32.51
RPS29.86
ROIC17.49
ROA13.63
Interest Cover13.34
EBITDA, mln1,410
EV / EBITDA25.50
EV / EBIT31.74
Revenue, mln4,541
EV / Revenue7.92

Quote Details

Last 235.99
Change -54.07 (-18.64%)
Open 255.77
Volume 5,382,606
Turnover 1,270,241,280
Average Volume 2,479,373

Financial Ratios

Pre-Tax Profit Margin23
Leverage Ratio2.17
Current Ratio2.63
Price / Book11.56
Price / Tangible Book24.71
Price / Cash Flow28.97
Price / Free Cash Flow33.10
Debt / Equity0.71
Price / Sales7.99
PEG Ratio2.91

Financial Strength

Altman Z-Score7.38
Piotroski F-Score 8 / 9
Beneish M-Score-2.68
Price to Intrinsic Value4.50
Price to Graham Number8.34
1-Year Target Price249.50
Short Ratio1.86
Short % of Float8.55

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -12.41% 8 / 100   
1 Month -11.19% 27 / 100   
2 Months 24.55% 94 / 100   
6 Months 73.8% 98 / 100   
1 Year 148% 99 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog